Stanislas Pol

43.1k citations
489 papers · 19.7k · 4 hit papers · h-index 74

Impact in

  • Hepatology top 0.01%
    • Hepatitis C virus research
    • Liver Disease and Transplantation
    • Hepatitis Viruses Studies and Epidemiology
    • Hepatocellular Carcinoma Treatment and Prognosis
  • Epidemiology top 0.05%
    • Liver Disease Diagnosis and Treatment
    • Hepatitis B Virus Studies

Papers in

    • Hepatitis C virus research 335
    • Liver Disease and Transplantation 30
    • Hepatitis Viruses Studies and Epidemiology 24
    • Hepatitis B Virus Studies 187
    • Liver Disease Diagnosis and Treatment 172

Stanislas Pol

466 papers receiving 19.0k citations

Stanislas Pol's Hit Papers

Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4–5 chronic kidney disease (the C-SURFER study): a combination phase 3 study 2015 · 493 citations
4930+8+16Years since publication50010001.5k

Peers

Stanislas Pol
Comparison fields: 5 of 148
  • Hepatology 13.2k
  • Epidemiology 11.0k
  • Transplantation 349
  • Infectious Diseases 2.2k
  • Virology 392
Replace Mark Sulkowski with:
Mark Sulkowski United States
Raymond T. Chung United States
Geoffrey Dusheiko United Kingdom
Ulrich Spengler Germany
Patrick Marcellin France
Heiner Wedemeyer Germany
A. Albertí Italy
Harry L.A. Janssen Netherlands
Janice K. Albrecht United States
Daniel Dhumeaux France
Stanislas Pol relative to Mark Sulkowski United States Mark Sulkowski's profile →
Citations per field
00.5×1.5×
Mark Sulkowski · 1×
Citations per year

Countries citing papers authored by Stanislas Pol

Since Specialization
Citations

This map shows the geographic impact of Stanislas Pol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stanislas Pol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stanislas Pol more than expected).

Fields of papers citing papers by Stanislas Pol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stanislas Pol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stanislas Pol. The network helps show where Stanislas Pol may publish in the future.

Co-authors

The 25 scholars most cited alongside Stanislas Pol, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stanislas Pol Line = papers co-authored together Stanislas Pol links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 489 papers — load more, or switch the sort, to bring in the rest.

#Work
1
FIB-4
Hit paper breakdown →
20071659
2
Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection
Hit paper breakdown →
2009800
3
Characterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing Particles
Hit paper breakdown →
2002551
4
Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4–5 chronic kidney disease (the C-SURFER study): a combination phase 3 study
Hit paper breakdown →
2015493
5 2001472
6 2011338
7 2017280
8 2007266
9 2012244
10 2008229
11 2015209
12 2003209
13 2014206
14 2016201
15 2005182
16 2004179
17 2019160
18 2009160
19 2010157
20 2004154

About Stanislas Pol

Stanislas Pol is a scholar working on Hepatology, Epidemiology, Infectious Diseases, Rheumatology and Immunology, having authored 489 papers that have together received 19.7k indexed citations. Recurring topics across this work include Hepatitis C virus research (335 papers), Hepatitis B Virus Studies (187 papers), Liver Disease Diagnosis and Treatment (172 papers), Systemic Lupus Erythematosus Research (46 papers), HIV/AIDS drug development and treatment (35 papers), Liver Disease and Transplantation (30 papers), Hepatitis Viruses Studies and Epidemiology (24 papers) and Alcohol Consumption and Health Effects (17 papers). The work is most often cited by research in Hepatology (13.2k citations), Epidemiology (11.0k citations), Transplantation (349 citations), Infectious Diseases (2.2k citations) and Virology (392 citations). Stanislas Pol has collaborated with scholars based in France, United States and Germany. Frequent co-authors include Anaïs Vallet‐Pichard, Bertrand Nalpas, Vincent Mallet, Christian Bréchot, Hélène Fontaine, Virginie Verkarre, Valérie Dhalluin-Venier, P. Cacoub, Marc Bourlière and Valérie Thiers. Their work appears in journals such as Journal of Hepatology, Hepatology, Journal of Viral Hepatitis, Liver International and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact